PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.
http://ww2.peerview.com
Gesamtlänge aller Episoden: 6 days 1 hour 23 minutes
Riccardo Lencioni, MD, FSIR, EBIR - At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma: Preparing for the Next Evolution in Multimodal Treatment
Go online to www.peerview.com/ZCA860 to view the entire programme with slides.
Ira M. Jacobson, MD - HCV From Screening to Cure: A Closer Look at Changing At-Risk Populations and an Evolving Treatment Landscape
Go online to www.peerview.com/FNC860 to view the entire programme with slides.
Ghassan Abou-Alfa, MD, MBA - Teaming Up to Improve Outcomes in Advanced Hepatocellular Carcinoma: A Tumor Board Evaluating the Potential of Immunotherapy and Novel Targeted Approaches
Go online to www.peerview.com/EMA860 to view the entire programme with slides.
Andrew H. Ko, MD - The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches
Go online to www.peerview.com/NMJ860 to view the entire programme with slides.
Ghassan Abou-Alfa, MD, MBA - New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised For Transformation?
Go online to www.peerview.com/PVM860 to view the entire programme with slides.
Naiyer Rizvi, MD - Moving in Leaps and Bounds Towards Precision Immuno-Oncology: Latest Biomarker Strategies to Guide Patient Selection and Maximize the Potential of Cancer Immunotherapies
Go online to www.peerview.com/UPW860 to view the entire programme with slides.
Robin L. Jones, MD - Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes
Go online to www.peerviewpress.com/HVC860 to view the entire programme with slides.
David L. Rimm, MD, PhD - The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists
Go online to www.peerviewpress.com/HGJ860 to view the entire programme with slides.
Ghassan Abou-Alfa, MD, MBA - The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances
Go online to www.peerviewpress.com/EZN860 to view the entire programme with slides.